Kaletra and Takotsubo cardiomyopathy - from FDA reports


Summary

Takotsubo cardiomyopathy is reported only by a few people who take Kaletra. We study 17,222 people who have side effects while taking Kaletra from FDA. Among them, 1 have Takotsubo cardiomyopathy. Find out below who they are, when they have Takotsubo cardiomyopathy and more.

What to expect?

If you take Kaletra and have Takotsubo cardiomyopathy, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 20, 2017

17,222 people reported to have side effects when taking Kaletra.
Among them, 1 person (0.01%) has Takotsubo cardiomyopathy


Number of reports submitted per year:

Could Kaletra cause Takotsubo cardiomyopathy?

Time on Kaletra when people have Takotsubo cardiomyopathy *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 100 %

Age of people who have Takotsubo cardiomyopathy when taking Kaletra *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Pain (1 person, 100.00%)
  • Neuralgia (1 person, 100.00%)
  • Muscle Spasms (1 person, 100.00%)
  • Depression (1 person, 100.00%)
  • Antiinflammatory Therapy (1 person, 100.00%)

Top co-used drugs for these people *:

  • Voltaren (1 person, 100.00%)
  • Oxycontin (1 person, 100.00%)
  • Metformin (1 person, 100.00%)
  • Axiron (1 person, 100.00%)
  • Ambien (1 person, 100.00%)

Top other side effects for these people *:

  • Acute Coronary Syndrome (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Takotsubo cardiomyopathy when taking Kaletra?

Expand the study to include all drugs with the same ingredients

Takotsubo cardiomyopathy and drugs with ingredients of lopinavir; ritonavir.

Expand the study to include reports from both FDA and eHealthMe

Takotsubo cardiomyopathy and Kaletra from FDA and eHealthMe reports

Kaletra

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)

Takotsubo cardiomyopathy

Takotsubo cardiomyopathy has been reported by people with high blood pressure, depression, rheumatoid arthritis, osteoporosis, anaphylaxis (latest reports from 2,076 Takotsubo cardiomyopathy patients).

Browse all side effects of Kaletra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Takotsubo cardiomyopathy

Takotsubo cardiomyopathy

Could your condition cause Takotsubo cardiomyopathy

Takotsubo cardiomyopathy

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Kaletra and have Takotsubo cardiomyopathy.

Questions to the study

More questions >

User reviews to the study

More reviews >